Antisense and RNAi Therapeutics Market by Type, Application, and Geography - Forecast and Analysis 2021-2025

Executive Summary

Market Landscape

• Market ecosystem
• Value chain analysis

Market Sizing

• Market definition
• Market segment analysis
• Market size 2020
• Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

• Five forces analysis
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

Market Segmentation by Type

• Market segments
• Comparison by Type
• Antisense therapy - Market size and forecast 2020-2025
• RNAi therapy - Market size and forecast 2020-2025
• Market opportunity by Type

Market Segmentation by Application

• Infectious diseases
• Cardiovascular diseases
• Cancer
• Metabolic disorder
• Others

Customer landscape

Geographic Landscape

• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2020-2025
• Europe - Market size and forecast 2020-2025
• Asia - Market size and forecast 2020-2025
• ROW - Market size and forecast 2020-2025
• Key leading countries
• Market opportunity by geography
• Market drivers
• Market challenges
• Market trends

Vendor Landscape

• Vendor landscape
• Landscape disruption
• Industry risks
• Competitive scenario

Vendor Analysis

• Vendors covered
• Market positioning of vendors
• Alnylam Pharmaceuticals Inc.
• Arrowhead Pharmaceuticals Inc.
• Bausch Health Companies Inc.
• Biogen Inc.
• Boehringer Ingelheim International GmbH
• Dicerna Pharmaceuticals Inc.
• Ionis Pharmaceuticals Inc.
• Moderna Inc.
• Sanofi
• Sarepta Therapeutics Inc.

Appendix

• Scope of the report
• Currency conversion rates for US$
• Research methodology
• List of abbreviations